Mind Medicine (MindMed) I... (MNMD)
NASDAQ: MNMD
· Real-Time Price · USD
7.16
-0.14 (-1.92%)
At close: Jun 13, 2025, 3:59 PM
7.00
-2.17%
After-hours: Jun 13, 2025, 05:56 PM EDT
-1.92% (1D)
| Bid | 6.96 |
| Market Cap | 540.58M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -77.63M |
| EPS (ttm) | -0.75 |
| PE Ratio (ttm) | -9.54 |
| Forward PE | -4.71 |
| Analyst | Buy |
| Ask | 7.27 |
| Volume | 664,890 |
| Avg. Volume (20D) | 1,145,820 |
| Open | 7.06 |
| Previous Close | 7.30 |
| Day's Range | 7.00 - 7.30 |
| 52-Week Range | 4.70 - 10.44 |
| Beta | 2.88 |
About MNMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MNMD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MNMD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+8.42%
Mind Medicine and Compass Pathways shares are trad...
Unlock content with
Pro Subscription
4 months ago
+7.68%
Mind Medicine shares are trading higher after Evercore ISI Group initiated coverage on the stock with an Outperform rating and announced a $23 price target.
1 month ago · seekingalpha.com
Mind Medicine (MindMed) Inc. (MNMD) Q1 2025 Earnings Call TranscriptMind Medicine (MindMed) Inc. (NASDAQ:MNMD ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - Chief Executive ...
1 month ago · businesswire.com
MindMed to Report First Quarter 2025 Financial Results on May 8, 2025NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain...